After validating the four independent GEP cohorts included GSE2658, GSE9782, GSE19784 and GSE136337, we found that high expression of DAZAP1 were distinctly associated with poor survival of MM patients (Figure 1B–1F). This evidence concerns the gene DAZAP1 and Miyoshi myopathy.